Natriumklorid B. Braun (Sodium Chloride)

Sodium chloride provides Na+ and Cl- ions that expand the extracellular fluid compartment. The added sodium creates an osmotic gradient that draws water into the vascular space, increasing blood volume. Chloride maintains electrical neutrality, helping to stabilize membrane potentials and supporting normal physiological functions.

The dose of Natriumklorid B. Braun is determined by the prescribing clinician based on the patient’s fluid status, electrolyte levels, and clinical condition. Dosage is individualized and may be adjusted during therapy according to ongoing monitoring of vital signs and laboratory results.

Safety data for Natriumklorid B. Braun in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To order Natriumklorid B. Braun, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Natriumklorid B. Braun is a standard isotonic sodium chloride injection comparable to other 0.9% saline products. Its EU‑origin manufacturing and strict GDP compliance may offer assurance of consistent sterility and isotonicity. Clinically, it provides the same electrolyte composition as other normal saline solutions, making it interchangeable when appropriate.

Store Natriumklorid B. Braun at ambient temperature, preferably below 25 °C, in its original container. Protect the product from direct sunlight, moisture, and physical damage. Do not freeze the solution, and inspect the vial for particulate matter before use.

The product is administered intravenously, either as a slow infusion or a rapid bolus, depending on the clinical situation. Administration should be performed by qualified healthcare personnel using aseptic technique, and the infusion rate should be adjusted according to patient response and monitoring parameters.

Serious risks include severe hypernatremia, fluid overload leading to pulmonary edema, cardiac arrhythmias due to electrolyte imbalance, and rare anaphylactic reactions. Continuous monitoring of vital signs, fluid balance, and serum electrolytes helps mitigate these risks.

Patients with known hypersensitivity to sodium chloride or any component of the formulation should avoid its use. Caution is advised in individuals with severe renal impairment, uncontrolled heart failure, or conditions predisposing them to fluid overload, where alternative fluid management strategies may be preferred.